269 related articles for article (PubMed ID: 30418194)
1. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Liang H; Ai-Jun J; Ji-Zong Z; Jian-Bo H; Liang Z; Yong-Xiang Y; Chen Y
Anticancer Drugs; 2019 Feb; 30(2):186-194. PubMed ID: 30418194
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
3. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
[TBL] [Abstract][Full Text] [Related]
5. MiR-559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro.
Zheng XS; Liu HJ; Zhang LL; Li H; Wang CJ; Xin YJ; Hao R
Kaohsiung J Med Sci; 2020 Oct; 36(10):793-798. PubMed ID: 32492286
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
8. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
[TBL] [Abstract][Full Text] [Related]
9. [Expression of miR-212 and miR-132 in serum of patients with primary liver cancer and their targeted regulation of GP73].
Sha M; Wang B; Xiao L; Ye J; Wang J; Luan ZY
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):920-926. PubMed ID: 29325293
[No Abstract] [Full Text] [Related]
10. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation.
Sai WL; Yao M; Shen SJ; Zheng WJ; Sun JY; Wu MN; Wang L; Yao DF
Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):449-454. PubMed ID: 32171652
[TBL] [Abstract][Full Text] [Related]
11. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
14. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
Chen P; Zhao X; Ma L
Mol Cell Biochem; 2013 Nov; 383(1-2):49-58. PubMed ID: 23842624
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
[TBL] [Abstract][Full Text] [Related]
17. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
18. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
[TBL] [Abstract][Full Text] [Related]
19. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
20. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
